同和药业获得欧洲药典适应性证书

Group 1 - The company, Tonghe Pharmaceutical (300636.SZ), has received a revised Certificate of Suitability (CEP) for the raw material drug Ticagrelor from the European Directorate for the Quality of Medicines (EDQM) [1] - The revision is due to the addition of a new production workshop, and the certification scope includes Ticagrelor raw material [1] - The revised certificate will be effective from September 12, 2025 [1]